These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35397094)

  • 1. Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
    Kostic D; Dincic E; Jovanovski A; Kostic S; Rancic N; Georgievski-Brkic B; Misovic M; Koprivsek K
    Acta Neurol Belg; 2023 Jun; 123(3):831-838. PubMed ID: 35397094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Dadar M; Mahmoud S; Narayanan S; Collins DL; Arnold DL; Maranzano J
    Brain; 2022 Jun; 145(6):2008-2017. PubMed ID: 34927199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEST 2022 - Differences in APT-weighted signal in T1 weighted isointense lesions, black holes and normal-appearing white matter in people with relapsing-remitting multiple sclerosis.
    Khormi I; Al-Iedani O; Casagranda S; Papageorgakis C; Alshehri A; Lea R; Liebig P; Ramadan S; Lechner-Scott J
    Magn Reson Imaging; 2023 Oct; 102():212-221. PubMed ID: 37321380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis.
    Thaler C; Faizy TD; Sedlacik J; Holst B; Stürner K; Heesen C; Stellmann JP; Fiehler J; Siemonsen S
    AJNR Am J Neuroradiol; 2017 Feb; 38(2):264-269. PubMed ID: 28059711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.
    Radue EW; Sprenger T; Vollmer T; Giovannoni G; Gold R; Havrdova E; Selmaj K; Stefoski D; You X; Elkins J
    Eur J Neurol; 2016 Feb; 23(2):412-5. PubMed ID: 26806217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
    Elliott C; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Wei W; Belachew S; Arnold DL
    Mult Scler; 2019 Dec; 25(14):1915-1925. PubMed ID: 30566027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis.
    Calvi A; Tur C; Chard D; Stutters J; Ciccarelli O; Cortese R; Battaglini M; Pietroboni A; De Riz M; Galimberti D; Scarpini E; De Stefano N; Prados F; Barkhof F
    Neuroimage Clin; 2022; 35():103048. PubMed ID: 35598462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
    Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM
    Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative susceptibility mapping of both ring and non-ring white matter lesions in relapsing remitting multiple sclerosis.
    Coffman CH; White R; Subramanian K; Buch S; Bernitsas E; Haacke EM
    Magn Reson Imaging; 2022 Sep; 91():45-51. PubMed ID: 35605736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study.
    Arnold DL; You X; Castrillo-Viguera C
    J Neurol; 2017 Aug; 264(8):1728-1734. PubMed ID: 28685353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
    Amaral LLFD; Fragoso DC; Rocha AJD
    Arq Neuropsiquiatr; 2019 Jul; 77(7):485-492. PubMed ID: 31365640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.
    do Amaral LLF; Fragoso DC; Nunes RH; Littig IA; da Rocha AJ
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):614-619. PubMed ID: 30846435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.
    Maranzano J; Rudko DA; Nakamura K; Cook S; Cadavid D; Wolansky L; Arnold DL; Narayanan S
    Neurology; 2017 Aug; 89(7):714-721. PubMed ID: 28724581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients.
    Nowaczyk N; Kalinowska-Łyszczarz A; Paprzycki W; Michalak S; Kaźmierski R; Pawlak MA
    Neurol Neurochir Pol; 2019; 53(1):18-25. PubMed ID: 30742302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis.
    Ciccarelli O; Giugni E; Paolillo A; Mainero C; Gasperini C; Bastianello S; Pozzilli C
    Eur J Neurol; 1999 Jul; 6(4):455-9. PubMed ID: 10362899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.
    Chiang GC; Pinto S; Comunale JP; Gauthier SA
    J Neuroimaging; 2016 May; 26(3):289-95. PubMed ID: 26458494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
    Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
    Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
    PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.